1. In Vivo
  2. >>ESG
  3. >>Diversity & Inclusion

Podcast: All About Unlocking Eve – The Initiative Advancing Women In Healthcare Leadership

In Vivo sat down with Eva McLellan and Kaye Vitug to discuss Unlocking Eve, an initiative to bring more women into positions of healthcare leadership

 
• By Chloe Kent

In Vivo's Chloe Kent discussed the future of women in healthcare leadership with Roche executives and Unlocking Eve founders Eva McLellan and Kaye Vitug.

In Vivo Podcast
• Source: Shutterstock

Self-described as a "movement for transformational change", Unlocking Eve is an initiative which focuses on elevating women in leadership and decision-making roles throughout the healthcare space. Founded by senior Roche Holding AG executives Eva McLellan and Kaye Vitug, the organization recently hosted its debut panel event at the 2022 World Economic Forum in Davos.

In Vivo reporter Chloe Kent sat down with the founders to discuss why women are so underrepresented healthcare leadership, and what employers and the industry

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diversity & Inclusion

RESILIENCE Initiative Navigates The World Of Making Medicines Through VR Technology

 
• By Anabel Costa-Ferreira

The process of manufacturing medicines can often be complex, expensive and harmful to the environment. Initiatives like RESILIENCE UK are seeking to simplify this process, utilizing VR technology to create a more sustainable learning environment for both students and companies.

Cracking Through ‘The Bamboo Ceiling’: East Asians Reach For Pharma Leadership

 
• By Brian Yang

Despite the significant presence of East Asian professionals in the pharmaceutical industry, their representation in top leadership roles remains disproportionately low. This disparity can be attributed to cultural bias, limited access to influential networks, and systemic barriers within corporate structures.

Infographic: Analyzing The Gap In Women’s Health Care

 
• By Anabel Costa-Ferreira

Looking at a recent McKinsey report alongside our Evaluate data, the below infographic provides insight into the investment scene of pharma and raises questions as to how the industry is seemingly yet to seize the opportunity in women's health.

Growing Calls For Labelling Changes With Obesity Patients In Mind

 
• By Ed Silverman

Despite significant investments in weight loss treatments, pharmaceutical companies face criticism for neglecting to study their drugs in obese patients, possibly leading to incomplete labeling and patient risks, prompting calls for the FDA to enforce more inclusive clinical trials and updated drug information.

More from ESG

Global Regulator Action To Improve Diversity In Clinical Trials

 
• By Vibha Sharma

As efforts to improve diversity in clinical trials gain momentum globally, regulators in the UK, the EU, Canada, Australia and Japan were asked about their efforts to support representative enrolment. 

Providing The Balance Between Medtech Innovation And Providers’ Sustainability

 
• By Ashley Yeo

Royal Philips is at the forefront of the driving environmental sustainability along the Scope 1-2-3 chain. The company hosted a round table in Amsterdam to hear experiences from providers.

FDA Publishes Updated Roadmap For Advancing Women’s Health

 
• By Brian Bossetta

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.